Mantle cell lymphoma treatment offers options if patients relapse after CAR T-cell therapy, from bispecific antibodies, antibody drug conjugates, and other emerging therapies.

Researchers sought to determine whether dual-targeted CAR-T therapy would be effective for patients with relapsed or refractory MCL.

Many casino gamblers expect to lose money. And they are rarely disappointed. But advantage players do the opposite. As ...

Beloved Australian actor, Magda Szubanski, has revealed she's been diagnosed with a "very rare, very aggressive, very serious" blood cancer called mantle cell lymphoma.

A rapidly developed, dual-target chimeric antigen receptor T-cell therapy produced a 100% overall response rate in patients with relapsed or refractory mantle cell lymphoma in a phase 1/2 study.In ...

The FDA has approved a new pill to treat adults with a type of blood cancer called mantle cell lymphoma (MCL).

The FDA has approved Calquence® in combination with bendamustine and rituximab for the treatment of adults with previously untreated MCL.

This approval also converts CALQUENCE's accelerated approval for patients with mantle cell lymphoma who have received at least one prior therapy, granted in October 2017, to full approval for use ...

The "sledgehammer-like treatment" of stem cell transplants had no benefit for most mantle cell lymphoma patients, according to study reported at ASH.

Mantle cell lymphoma (MCL) is a rare and sometimes ruthless form of non-Hodgkin lymphoma. Even when treatment appears to be successful, the cancer often returns and is difficult to cure. A new therapy ...